As of 2024-12-11, the Fair Value of Crinetics Pharmaceuticals Inc (CRNX) is -14.98 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 57.17 USD, the upside of Crinetics Pharmaceuticals Inc is -126.21%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -50.42 | -73.81 | -107.64 | -163.92 | -214.53 | -122.06 |
| YoY growth | -85.91% | -46.39% | -45.83% | -52.29% | -30.87% | -52.26% |
| Market Cap (mil) | 5,301.95 |
| P/E | |
| Forward P/E |
| EPS | -3.00 |
| Avg earnings growth rate | -52.26% |
| TTM earnings | -277.91 |